Compare Edwards Lifesciences Corporation Common Stock (EW) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs MobilEye Global Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while MobilEye Global Inc trades at $7.07 (market cap $6.08B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 8.1× MobilEye Global Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.
| EW | MBLY | |
|---|---|---|
Market Cap | $49.44B | $6.08B |
Volume | 3,508,027 | 4,250,290 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $15.54 |
52-Week Low | $72.65 | $6.56 |
Enterprise Value | $45.90B | $4.64B |
Typical Hold Time | — | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mobileye Global (MBLY) trades at $7.06, down 5.49% today, reflecting ongoing bearish technical momentum. The stock shows mixed fundamentals with strong revenue growth to $1.89B in 2025 but significant net losses of -$392M. Recent earnings beat expectations in Q1 and Q2 2026, while analyst sentiment remains cautiously optimistic with a $10.83 consensus price target. Technical indicators signal bearish pressure with RSI levels suggesting potential oversold conditions.
The outlook remains challenging with persistent losses and negative profit margins, though the company maintains leadership in ADAS technology and shows operational cash flow strength. Key risks include execution on autonomous driving initiatives and competitive pressures. The current valuation below book value presents potential upside if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
